2018年7月31日星期二

MAGL inhibitor and FAAH Inhibitor : JW-642 & OL-135 & PF-750 丨AASraw

MAGL inhibitor and FAAH Inhibitor : JW-642 & OL-135 & PF-750 丨AASraw

1. JW-642 Review 1
2. Biological Activity--CAS: 1416133-89-5 2
3. OL-135 Review 2
4. Biological Activity--CAS: 681135-77-3 3
5. PF-750 Review 3
6. Biological Activity--CAS: 959151-50-9 4
7. JZL-184 Review 5
8. Biological Activity--CAS: 1101854-58-3 6
9. Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group 6
10. Guide on buy JW-642 MAGL inhibitor step by step 7

1. JW-642 Review


JW-642 (1416133-89-5) is a potent, selective monoacylglycerol lipase (MAGL) inhibitor with IC50 of 7.6, 14 and 3.7 nM for mouse, rat and human MAGL, respectively. Endocannabinoids such as 2-arachidonoyl glycerol (2-AG) and arachidonoyl ethanolamide are biologically active lipids that are involved in a number of synaptic processes including activation of cannabinoid receptors. Monoacylglycerol lipase (MAGL) is a serine hydrolase responsible for the hydrolysis of 2-AG to arachidonic acid and glycerol, thus terminating its biological function. JW-642 is a potent inhibitor of monoacylglycerol lipase (MAGL) that displays IC50 values of 7.6, 14, and 3.7 nM for inhibition of MAGL in mouse, rat, and human brain membranes, respectively.1 JW-642 is selective for MAGL, requiring much higher concentrations to effectively inhibit fatty acid amide hydrolase activity (IC50s = 31, 14, and 20.6 µM for mouse, rat, and human brain membranes, respectively).
JW-642 TECHNICAL DATA
Product nameJW-642
CAS number1416133-89-5
FormulaC21H20F6N2O3
M.Wt462.39
SolubilitySoluble in DMSO > 10 mM    Storage    Store at -20°C
Physical AppearanceA solution in methyl acetate
Shipping ConditionEvaluation sample solution : ship with blue ice.All other available size: ship with RT , or blue ice upon request
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.

2. Biological Activity--CAS: 1416133-89-5


JW-642 is a potent inhibitor of monoacylglycerol lipase (MAGL) that displays IC50 values of 7.6, 14, and 3.7 nM for inhibition of MAGL in mouse, rat, and human brain membranes, respectively. IC50: 7.6/14/3.7 nM (mouse/rat/human MAGL)
Target: MAGL inhibitor JW-642 is selective for MAGL, requiring much higher concentrations to effectively inhibit fatty acid amide hydrolase activity (IC50s = 31, 14, and 20.6 M for mouse, rat, and human brain membranes, respectively).

3. OL-135 Review


OL-135 is a CNS penetrant, highly potent and selective reversible inhibitor of FAAH. OL-135 exhibits analgesic pharmacology in various animal models without the motor impairment associated with direct CB1 agonism.FAAH Inhibitor OL-135 disrupts the acquisition, but not consolidation, of contextual fear conditioning.Auditory fear conditioning and shock reactivity remain unaffected.Together, these data suggest a specific role for endocannabinoids in a subset of fear conditioning paradigms.
OL-135 TECHNICAL DATA
Product NameOL-135
CAS number681135-77-3
AppearanceSolid powder
Purity>98% (or refer to the Certificate of Analysis)
Shipping ConditionShipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage ConditionDry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
SolubilitySoluble in DMSO, not in water
Shelf Life>2 years if stored properly
Drug FormulationThis drug may be formulated in DMSO
Stock Solution Storage0 - 4 C for short term (days to weeks), or -20 C for long term (months)

4. Biological Activity--CAS: 681135-77-3


OL-135 is a CNS penetrant, highly potent and selective reversible inhibitor of FAAH devoid of CB1, CB2 and μ and δ opioid receptors activities that increases the analgesic and hypothermic activity of anandamide.

5. PF-750 Review


Fatty acid amide hydrolase (FAAH) is the enzyme responsible for hydrolysis and inactivation of fatty acid amides including anandamide and oleamide. PF-750 is a potent, time-dependent, irreversible FAAH inhibitor with IC50 values of 0.6 and 0.016 µM when preincubated with recombinant human FAAH for 5 and 60 minutes, respectively.1 Activity-based profiling of various human and murine tissue proteome samples revealed that PF-750 is highly selective for FAAH relative to other serine hydrolases, showing no discernable off-site activity up to 500 µM.
PF-750 TECHNICAL DATA
Product namePF-750
CAS number959151-50-9
AppearanceSolid powder
Purity>98% (or refer to the Certificate of Analysis)
Shipping ConditionShipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage ConditionDry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
SolubilitySoluble in DMSO
Shelf Life>2 years if stored properly
Drug FormulationThis drug may be formulated in DMSO
Stock Solution Storage0 - 4 C for short term (days to weeks), or -20 C for long term (months)

6. Biological Activity--CAS: 959151-50-9


PF-750 is a potent, time-dependent, irreversible FAAH inhibitor with IC50 values 0.6 and 0.016 μM when preincubated with recombinant human FAAH for 5 and 60 minutes, respectively. Fatty acid amide hydrolase (FAAH) is the enzyme responsible for hydrolysis and inactivation of fatty acid amides including anandamide and oleamide. Activity-based profiling of various human and murine tissue proteome samples revealed that PF-750 is highly selective for FAAH relative to other serine hydrolases, showing no discernable off-site activity up to 500 μM. PF-750 shows 10-fold better potency than URB597 (Sigma# U4133) after 30 min preincubation. PF-750 is highly selective on FAAH. Even at as high as 500 μM, it had no interactions with many tested enzymes, but URB597 and other known FAAH inhibitors did not perform well at low concentraction (100 μM).

7. JZL-184 Review


JZL-184(1101854-58-3) is a potent and selective inhibitor of MAGL with IC50 of 8 nM and 4 μM for inhibition of MAGL and FAAH in mouse brain membranes respectively. IC50 value: 8 nM Target: MAGL inhibitor in vitro: JZL-184 prolongs DSE in Purkinje neurons in cerebellar slices and DSI in CA1 pyramidal neurons in hippocampal slices. JZL-184 is more potent in inhibiting mouse MAGL than rat MAGL. in vivo: When administered to mice at 16 mg/kg, intraperitoneally, JZL-184 reduces MAGL activity by 85%, elevates brain 2-AG levels by 8-fold, and elicits analgesic activity in a variety of pain assays that qualitatively mimics direct central cannabinoid (CB1) agonists. Acute administration of JZL-184 to FAAH(-/-) mice enhanced the magnitude of a subset of cannabimimetic responses, repeated JZL-184 treatment led to tolerance to its antinociceptive effects, cross-tolerance to the pharmacological effects of Δ-tetrahydrocannabinol, decreases in CB1 receptor agonist-stimulated guanosine 5'-O-(3-[(35)S]thio)triphosphate binding, and dependence as indicated by rimonabant-precipitated withdrawal behaviors, regardless of genotype.
JZL -184 TECHNICAL DATA
Alternative NameJZL-184
FormulaFormula
MW520.5
SourceAASraw
CAS1101854-58-3
Purity≥98% (TLC)
AppearancePale yellow solid
SolubilitySoluble in DMSO (10mg/ml)

8. Biological Activity--CAS: 1101854-58-3


JZL-184 selectively inhibits MAGL, the enzyme predominantly responsible for the degradation of the endocannabinoid 2-arachidonoylglycerol (2-AG). Anandamide and 2-AG are the two endogenous endocannabinoids that activate the cannabinoid receptors CB1 and CB2. Anandamide is predominantly metabolized by fatty acid amide hydrolase (FAAH), whereas monoacylglycerol lipase (MAGL) is thought to be the enzyme primarily responsible for the degradation of 2-AG. It is difficult to separate the activities of the two because most currently available inhibitors of MAGL are not selective, and also inhibit FAAH or other enzymes. JZL-184 is the first selective inhibitor of MAGL with nanomolar portency and over 200-fold selectivity for MAGL vs FAAH. When administered to mice,  JZL-184 increased levels of 2-arachidonoylglycerol in the brain by about 8-fold, with no effect on levels of anandamide.

9. Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group


The endocannabinoids 2-arachidonoyl glycerol (2-AG) and N-arachidonoyl ethanolamine (anandamide) are principally degraded by monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH), respectively. The recent discovery of O-aryl carbamates such as JZL-184 as selective MAGL inhibitors has enabled functional investigation of 2-AG signaling pathways in vivo. Nonetheless, JZL-184 and other reported MAGL inhibitors still display low-level cross-reactivity with FAAH and peripheral carboxylesterases, which can complicate their use in certain biological studies. Here, we report a distinct class of O-hexafluoroisopropyl (HFIP) carbamates that inhibits MAGL in vitro and in vivo with excellent potency and greatly improved selectivity, including showing no detectable cross-reactivity with FAAH. These findings designate HFIP carbamates as a versatile chemotype for inhibiting MAGL and should encourage the pursuit of other serine hydrolase inhibitors that bear reactive groups resembling the structures of natural substrates.
JW-642 (1416133-89-5) is a potent, selective monoacylglycerol lipase (MAGL) inhibitor with IC50 of 7.6, 14 and 3.7 nM for mouse, rat and human MAGL, respectively.


10. Guide on buy JW-642 MAGL inhibitor step by step


♦ Google AASraw, enter into www.aasraw.com.
♦ Search JW-642 Powder(1416133-89-5) on AASraw
♦ Find out JW-642 Powder windows XP, and write down your requirmnets.
♦ We get your email and talk more details with you.
♦ Confirm the order, then payment done and we will arrange delivery goods for you later.


2018年7月25日星期三

The Dual FAAH/MAGL Inhibitor JZL195 Compare With MAGL Inhibitor JZL184

The Dual FAAH/MAGL Inhibitor JZL195 Compare With MAGL Inhibitor JZL184


1. What is JZL195?

JZL195 ,1210004-12-8 is a potent and selective dual inhibitor of FAAH and monacylglycerol lipase (MAGL). JZL195 has greater anti-allodynic efficacy than selective FAAH, or MAGL inhibitors, plus a greater therapeutic window than a cannabinoid receptor agonist. JZL195 may have greater potential in alleviating neuropathic pain, compared to selective FAAH and MAGL inhibitors, or cannabinoid receptor agonists.

2. How does JZL195 work?

Fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) mediate the hydrolysis of the endocannabinoids arachidonoyl ethanolamide (AEA) and 2-arachidonoylglycerol (2-AG), respectively. JZL 195 is a potent inhibitor of both FAAH and MAGL (IC50s = 2 and 4 nM, respectively).1 It poorly inhibits neuropathy target esterase and ABHD6 and does not inhibit other brain serine hydrolases. JZL 195 displays time-dependent inhibition of FAAH and MAGL in vivo, consistent with a covalent mechanism of activation. The in vivo inhibitory actions of JZL 195(1210004-12-8) against FAAH and MAGL are comparable to those of the selective inhibitors PF-3845and JZL 184 , respectively.1 Through its inhibitory actions, JZL195 simultaneously augments brain levels of AEA and 2-AG, producing antinociceptive, cataleptic, and hypomotility effects like those produced by direct CB1 agonists.

3. What is JZL195 effects

JZL195 effects,JZL195 and the cannabinoid receptor agonist WIN55212 produced dose-dependent reductions in CCI-induced mechanical and cold allodynia, plus side effects including motor incoordination, catalepsy and sedation. JZL195 reduced allodynia with an ED50 at least four times less than that at which it produced side effects. By contrast, WIN55212 reduced allodynia and produce side effects with similar ED50s. The maximal anti-allodynic effect of JZL195 was greater than that produced by selective FAAH, or MAGL inhibitors. The JZL195-induced anti-allodynia was maintained during repeated treatment.

4. JZL195 compare with JZL184

-Chemical characteristics

Dual FAAH/MAGL Inhibitor JZL195 compare with MAGL Inhibitor JZL184
NameJZL195JZL184
CAS 1210004-12-81101854-58-3
Synonyms:JZL 195;4-nitrophenyl 4-(3-phenoxybenzyl)piperazine-1-carboxylate;4-[(3-Phenoxyphenyl)methyl]-1-piperazinecarboxylic acid 4-nitrophenyl esterJZL 184;4-Nitrophenyl 4-[bis(1,3-benzodioxol-5-yl)(hydroxy)Methyl]-1-piperidinecarboxylate;4-[Bis(1,3-benzodioxol-5-yl)hydroxymethyl]-1-piperidinecarboxylic acid 4-nitrophenyl ester;1-Piperidinecarboxylic acid, 4-[bis(1,3-benzodioxol-5-yl)hydroxymethyl]-, 4-nitrophenyl ester;4-[Bis(1,3-benzodioxol-5-yl)hydroxymethyl]-1-piperidinecarboxylic acid 4-nitrophenyl ester JZL 184;JZL 184 JZL184 JZL-184
MF:C24H23N3O5C27H24N2O9
Molecular structure diagramJZL195,1210004-12-81210004-12-8
MW:C24H23N3O5520.48746
Description JZL195 is a potent dual inhibitor of Monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH), enzymes that degrade the endocannabinoids 2-arachidonoylglycerol (2-AG) and anandamide (AEA), the endogenous ligands for the cannabinoid G-protein coupled receptors CB1 and CB2. IC50 values are 2 nM for MAGL and 4 nM for FAAH. JZL195 has been shown to inhibit endocannabinoid hydrolysis and elevate 2-AG and AEA levels in vivo.JZL184 is an irreversible inhibitor for monoacylglycerol lipase (MAGL), the primary enzyme responsible for degrading the endocannabinoid 2-arachidonoylglycerol (2-AG).[1] It displays high selectivity for MAGL over other brain serine hydrolases, including the anandamide-degrading enzyme fatty acid amide hydrolase (FAAH), thereby making it a useful tool for studying the effects of endogenous 2-AG signaling, in vivo. Administration of JZL184 to mice was reported to cause dramatic elevation of brain 2-AG leading to several cannabinoid-related behavioral effects.
Manufacturerwww.aasraw.com www.aasraw.com
Price Inquiry Inquiry 
Package Foil bag or Customization Foil bag or Customization
Delivery Within 12 hours in working day Within 12 hours in working day 

- Effects 

Endocannabinoids such as 2-arachidonoyl glycerol (2-AG) and arachidonoyl ethanolamide (AEA) are biologically active lipids that are involved in a number of synaptic processes including activation of cannabinoid receptors. Monoacylglycerol lipase (MAGL) is a serine hydrolase responsible for the hydrolysis of 2-AG to arachidonic acid and glycerol, thus terminating its biological function. JZL 184 is a potent and selective inhibitor of monoacylglycerol lipase (MAGL) that displays IC50 values of 8 nM and 4 µM for inhibition of MAGL and fatty acid amide hydrolase in mouse brain membranes, respectively.1 When administered to mice at 16 mg/kg, intraperitoneally, JZL 184 reduces MAGL activity by 85%, elevates brain 2-AG levels by 8-fold, and elicits analgesic activity in a variety of pain assays that qualitatively mimics direct central cannabinoid (CB1) agonists.
The biological actions of the endocannabinoids anandamide and 2-arachidonoyl glycerol (2-AG) are terminated by enzymatic hydrolysis of these lipids via fatty acid amide hydrolase (FAAH ) and monoacylglycerol lipase (MAGL), respectively. While several selective FAAH inhibitors have been developed and characterized in vitro and in vivo, none of the initial MAGL blockers have shown adequate potency and specificity for in vivo applications.
JZL195 effects
The analgesic efficacy of cannabinoids in chronic pain models is limited by side-effects. It has been proposed that this might be overcome by using agents which indirectly activate the endocannabinoid system. We examined the analgesic and side-effect profile of the dual FAAH/MAGL inhibitor JZL195 in an inflammatory pain model. The effect of systemic injections of a range of doses of JZL195 and the pan-cannabinoid receptor agonist WIN55212 were performed 1 day following intraplantar injection of CFA in C57BL/6 mice. JZL195 and WIN55212 both reduced mechanical allodynia and thermal hyperalgesia, and produced catalepsy and sedation in a dose dependent manner. Unlike WIN55212, JZL195 effects reduced allodynia at doses below those at which side-effects were observed. The effects of JZL195 and WIN55212 were abolished by co-application with the CB1 antagonist AM251. The CB2 antagonist also reduced the JZL195 anti-allodynia, and reversed the WIN55212 anti-allodynia. The reduction in allodynia produced by JZL195 was greater than that produced individually by the FAAH and MAGL inhibitors, URB597 and JZL184. These findings suggest that JZL195 reduces inflammation induced allodynia at doses below those which produce side-effects, and displays greater efficacy that FAAH or MAGL inhibitors. Thus, dual FAAH/MAGL inhibition has the potential to alleviate inflammatory pain with reduced cannabinoid-like side-effects.
Systemic administration of JZL195 or JZL184 reduced horizontal and vertical  motor activity dose-dependently, and increased time spent in immobility. In contrast to JZL195, which decreased motor activity at all doses tested, JZL184 was effective only at the highest dose (30 mg/kg, p<0.05). The motor effects of both JZL compounds are also presented as time course over a 60 min period.
AASraw

5. Buy JZL195 raw powder online 

Aasraw Biochemical Technology Co. Ltd, a cerified steroids raw powder manufacturer with ISO9001 in China  brings to you “JZL195, 1210004-12-8” a potent dual inhibitor of Monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH), enzymes that degrade the endocannabinoids 2-arachidonoylglycerol (2-AG) and anandamide (AEA), the endogenous ligands for the cannabinoid G-protein coupled receptors CB1 and CB2. IC50 values are 2 nM for MAGL and4 nM for FAAH. JZL195 has been shown to inhibit endocannabinoid hydrolysis andelevate 2-AG and AEA levels in vivo.



2018年7月20日星期五

Does AMP Citrate can Alternative DMAA?

Does AMP Citrate can Alternative DMAA?


1.What is AMP Citrate?

AMP Citrate(CAS 71776-70-0) is a compound by many names. Some may refer to it as methylpentanamine, while others call it 1,3-dimethylbutylamine. Whatever it is called, there’s one thing that is certain, this compound has a remarkable structural similarity to the now banned DMAA ingredient, once popular in many fat burners and pre workouts. As such, this new ingredient is now known as the"next DMAA".
Also known scientifically as “4-amino-2-methylpentane” (hence the AMP) and sometimes referred to as an herbal extract from “pouchong” or “Chinese white tea,” AMP citrate is a psychostimulatory compound that’s remarkably similar in structure to the now-infamous 1,3-dimethylamylamine, or DMAA.  This comes as no surprise when you look at another scientific name for AMP: 1,3-dimethylbutylamine, or DMBA.
The claims that AMP citrate(71776-70-0) is a naturally-occurring botanical supplement sound a lot like the old claims that DMAA originates from the geranium plant. Given that the DMAA-geranium link was strongly debated, it’d likely be wise to view the idea of AMP as a “tea extract” with some degree of skepticism.
In any event, commercially-available AMP is going to be synthetic, but note that this is not anything new – your vitamin C tablets are extremely likely to be synthetic as well.
Name:    DMAA powder
CAS:    13803-74-2
Molecular Formula:    C7H17N.HCl
Molecular Weight:    151.68
Melt Point:    199-199.5 °C
Storage Temp:    RT
Color:    White powder


2.What does AMP Citrate do for you?

Extrapolating from its older and slightly better-known sibling, AMP is purported to increase blood pressure and bloodflow along with helping focus, mood, and athletic performance — although the latter is somewhat dubious. DMAA’s long half-life of roughly 8 hours can likely be extended to its newer brother, as well, making AMP hard-hitting and long-lasting.
All of this analysis is contingent on AMP behaving similarly to DMAA, of course, which is where we again run into the big problem: AMP on its own just isn’t very well-researched yet. User experiences confirm similar but milder effects, but this is anecdote, not data.
Nonetheless, going by the countless accounts of great workouts with fantastic energy and mood benefits, it’s pretty clear that AMP does deliver on its promises for many. This is not surprising – this is essentially what many aliphatic amines do (an aliphatic amine is one which has no aromatic ring attached to the nitrogen, and often make for nice stimulant effect).

3.AMP Citrate Benefits

As mentioned above AMP citrate is a very close relative to DMAA or 1,3-dimethylamylamine. The close relationship between these two compounds can be best demonstrated by the fact that AMP citrate (methylpetanamine) and DMAA (AKA methylhexanamine) share the same basic structure, but DMAA contains an extra carbon in its skeleton. Because of these similarities, the effects of AMP citrate are very similar to DMAA. When consumed in small doses, AMP citrate is a strong central nervous system stimulant that can help increase energy, focus, and metabolism. In other words, if you have been looking for a DMAA alternative, this is as close as it will ever get.
DMAA had a structural similarity to amphetamines, which could potentially result in false drug tests. However because AMP citrate is one carbon short, it is further differentiated from amphetamines, and may be less likely to result in false positives. This however, is entirely spculative and has not been scientifically confirmed.
The most important action of AMP is the fact that it increase energy, so it enables you to work longer and harder. Another noteworthy feature is the increase in strength, both aerobic and anaerobic. AMP also leads to a higher concentration, mental clarity and acceleration of metabolism. This last feature allows fat burner based on this compound to obtain much better results. In other words, if you are looking for an alternative DMAA, you’re closer than ever. 
DMAA is structurally related to amphetamine, which can potentially lead to falsify drug tests. But however, due to the construction of AMP Citrate, can be distinguished from amphetamine. But at the moment, it is all a speculation and has not been scientifically confirmed.
Due to the similarity with DMAA, side effects of AMP are quite similar. High doses can cause shaking hands, rapid heartbeat and other related symptoms.

4.AMP Citrate Side Effects

Due to its similarities with DMAA, the side effects of AMP citrate are also quite similar. High doses can cause jitteriness, rapid heartbeat, and related symptoms. Users of AMP citrate have also reported that it can cause a DMAA-like crash after the effects have worn off.
Because AMP citrate is a new ingredient, there have been very few studies on the compound in relation to efficacy and safety. As such, it is recommend all users of AMP citrate to exercise caution, not consume more than recommended doses, and to not use it in conjunction with alcohol, or separate products or food that contain stimulants. If you are on medication or suffer from medical conditions, it is advised you to refrain from using products that contain this ingredient.
Due to the lack of scientific research on this compound, it should also be acknowledged that the information in this article is largely anecdotal and not based on hard facts. It is important for investigators to review the safety and efficiency of this ingredient in the near future.

5.AMP Citrate Dosage

As explained by Natural Micron, an industrial producer of supplements and extracts, AMP comes in two popular forms:
  • AMP Citrate, the most common, has a subtly sweet, lemonade-like taste, and is roughly 35% “active” by molecular mass. It goes best in powdered supplements that will be tasted.
  • DMBA HCl, also gaining some prominence, has a more bitter, chemical taste, but is more than twice as potent as its tastier counterpart at 74% “active” by mass. It’s ideally suited for volume-limited applications like capsules.
If you’re willing to jump into the world of exploratory stimulants, most users have anecdotally reported effectiveness in doses of 200-400mg of the citrate form, which is consistent with what many emerging products are using in their formulations.
This would correspond to a little under half of the HCl form, or roughly 95-190mg for DMBA HCl in a pill or tablet.
It’s true for all stimulants, but especially for under-researched ones: you should always start with low dosages, particularly when combined with other ingredients, and individual tolerance should be carefully and progressively assessed. Those with existing medical conditions should be particularly careful, and it’s always recommended to consult with your doctor.
Due to the lack of research behind this ingredient, it is difficult to establish a recommended dosage. However, its dosage is expected to be similar to that of DMAA, which is around 10 to 60 mg.
AMP citrate is most effective for boosting workout energy if taken around 30 minutes before a workout. For fat loss, it can be taken first thing in the morning or soon before meals.
Because of the lack of clinical trials on AMP, it is difficult to determine the recommended dose. However, it is expected that a dose would be higher than DMAA specifying it by about 100 to 350 mg. The time of effective action is about 4-6 hours.
It is most effective in order to increase energy during a workout. It is best to take a portion about 30 minutes before training. In order to increase your metabolism and fat loss, you should take it in the morning or just before a meal.
AMP works synergistically with caffeine, and because of that you can find often both substances in the pre-workout supplements.  In the case of using it “solo” there should be added 200-300 mg of caffeine in order to maximize benefits.

6.What is the difference of AMP Citrate and DMAA?

AMP Citrate is a powerful stimulant for nervous system. Does not occur naturally in large doses, but can be found in small amounts in Pouchong Tea, but it is believed that most of the AMP Citrate used in supplements is artificially synthesized.
As mentioned above, AMP Citrate is a very closely related to DMAA or 1,3-Dimethylamylamine. The close connection between these two compounds is best evidenced by the fact that AMP Citrate (methylpetanamine) and DMAA (Methylhexanamine) share the same basic structure, but the DMAA has extra carbon in the skeleton. Because of these similarities, effects of AMP Citrate are very similar to DMAA. Consumed in small doses, is a powerful stimulant for central nervous system.
The lack of research done on this chemical makes it impossible to authoritatively say that it’s safe.
Although several shorter-term studies on DMAA found no evidence of negative health implications in otherwise healthy individuals, the lack of long-term safety data along with some reports of DMAA being linked to adverse effects that included heart attacks led regulatory agencies, including the FDA, to ban the substance in dietary and nutritional supplements.
Given that the bulk of our understanding at this time is that “AMP is a lot like DMAA,” similar consideration should be given: if the FDA prohibition on DMAA worries you, you may want to avoid AMP until more data exists.
Outside the vagaries of the available safety information, a very typical set of stimulant side effects is associated with too much AMP or overall combined stimulant use: jitters, nervousness, anxiety, cardiovascular issues, and a low-energy “crash” are all possibilities for misuse.
In comparing with DMAA, many users have reported that the effects of AMP are somewhat less pronounced and less “harsh,” but similar in establishing rapid tolerance for regular stimulant consumers. Cross-tolerance with other compounds, resensitization, and the potential for physiological withdrawal are all not yet fully explored.

7.Does DMAA is safe for healthy athletes?

Another note on the safety bit: many believe that DMAA was never truly proven to be unsafe, especially when used properly and in low dosages by healthy individuals. The same may go for DMBA here.
Billions of servings of DMAA were safely sold, but the irresponsibility of a few ruined it for everyone else. As with everything, we caution you to start with low dosages, do not use it if you have any pre-existing medical conditions, and to never use more than the label states.
Point is, this one is likely going to end up the same as DMAA did, and after that, another one will arrive in its place. We urge you to follow the warnings above – this is likely a great-feeling stimulant for healthy athletes, but should not be used by those without a clean bill of health.

2018年7月18日星期三

MAGL inhibitor JJKK-048 (1515855-97-6) suppliers online 丨AASraw

MAGL inhibitor JJKK-048 (1515855-97-6) suppliers online 丨AASraw


MAGL inhibitor JJKK-048 (1515855-97-6) suppliers online 丨AASraw 1
1. JJKK-048 (1515855-97-6) 1
2. JJKK-048 Biochem/physiol Actions 2
3. JJKK-048 Applications 3
4. The Analysis Report of MAGL inhibitor JJKK-048 in vivo 3
(1) Introduction 3
(2) Proposed Mechanism of MAGL Inhibition by JJKK-048 5
(3) JJKK-048 Exhibits Remarkable MAGL Selectivity 6
(4) Discussion 7
(5) Conclusions 7
5. Buy JJKK-048 from Reliable JJKK-048 Suppliers online 8
(1) Reliable JJKK-048 Suppliers online--AASraw 8
(2) The Guide on buy JJKK-048 step by step 8

1. JJKK-048 (1515855-97-6)


JJKK-048 is an ultrapotent and highly selective inhibitors of monoacylglycerol lipase. JJKK-048 potently (IC50 < 0.4 nM) inhibited human and rodent MAGL. JJKK-048 displayed low cross-reactivity with other endocannabinoid targets. Monoacylglycerol lipase (MAGL) terminates the signaling function of the endocannabinoid, 2-arachidonoylglycerol (2-AG). During 2-AG hydrolysis, MAGL liberates arachidonic acid, feeding the principal substrate for the neuroinflammatory prostaglandins. In cancer cells, MAGL redirects lipid stores toward protumorigenic signaling lipids. Thus MAGL inhibitors may have great therapeutic potential.
TECHNICAL DATA Of JJKK-048
Product nameJJKK-048
CAS number1515855-97-6
AppearanceSolid powder
Purity>98% (or refer to the Certificate of Analysis)
Shipping ConditionShipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage ConditionDry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
SolubilitySoluble in DMSO, not in water
Shelf Life>2 years if stored properly
Drug FormulationThis drug may be formulated in DMSO
Stock Solution Storage0 - 4 C for short term (days to weeks), or -20 C for long term (months).

2. JJKK-048 Biochem/physiol Actions


JJKK-048 is a cell penetrant ultrapotent and highly selective inhibitor of monoacylglycerol lipase (MAGL) that exhibits a low cross-reactivity with other endocannabinoid targets. JJKK-048 is an irreversible inhibitor that binds to the active site S122. A potent, highly selective monoacylglycerol lipase (MAGL) with IC50 of <0.4 nM against human and rodent MAGL; exhibits extremely high potency in inhibiting MAGL in the brain and peripheral tissues and maintains good selectivity over other serine hydrolases; remarkably increases mouse brain 2-AG levels without affecting AEA levels, induces antinociception and dose-dependent hypomotility and hypothermia but no catalepsy in vivo.

3. JJKK-048 Applications


JJKK-048 inhibits monoacylglycerol lipase by terminating signaling pathway of 2-arachidonoylglycerol in mouse brain and human melanoma cell proteome. JJKK-048 can be classified as a MAGL inhibitor that has therapeutic potential for the treatment of cancers.

4. The Analysis Report of MAGL inhibitor JJKK-048 in vivo


(1) Introduction


Endocannabinoids are lipid-structured signaling molecules that act as natural ligands for cannabinoid CB1 and CB2 receptors, which are also the targets of the psychoactive component of Cannabis sativa. The two most intensively studied endocannabinoids are 2-arachidonoylglycerol (2-AG) and anandamide (AEA). Generally, endocannabinoids are synthesized on demand from plasma membrane phospholipid precursors, and after exerting their effect by activating specific receptors, they are rapidly degraded by enzymatic activity. The principal brain endocannabinoid is 2-AG, which regulates central nervous system development and synaptic plasticity. Endocannabinoids also regulate cognition, emotional functions, and food intake, and are involved in several pathophysiological processes, including pain and neurodegenerative diseases. However, for therapeutic purposes, direct activation of cannabinoid receptors has proved to be challenging due to the side effects affecting cognition and motor control.

Monoacylglycerol lipase (MAGL) is a serine hydrolase that catalyzes the hydrolysis of monoacylglycerols to their corresponding fatty acids and glycerol. MAGL has been suggested to be the main hydrolase terminating 2-AG actions in the brain, accounting for ∼85% of total 2-AG hydrolysis at the bulk brain level. The remaining ∼15% has been attributed mainly to two α/β-hydrolase domain–containing proteins (ABHDs), ABHD6 and ABHD12. According to recent studies, in addition to regulating synaptic 2-AG signaling, MAGL has been demonstrated to play a key role in controlling brain eicosanoid production. Notably, MAGL-catalyzed hydrolysis of 2-AG liberates arachidonic acid to be used as a precursor for the production of neuroinflammatory prostaglandins. The pharmacological or genetic inactivation of MAGL has attenuated neuroinflammation and exerted neuroprotective effects in mouse models of neurodegenerative diseases. Moreover, MAGL contributes to cancer pathogenicity by providing free fatty acids for the production of tumor-promoting bioactive lipids, such as lysophosphatidic acid and prostaglandins. Thus, pharmacological inhibitors of MAGL may have great therapeutic potential both by locally enhancing 2-AG levels and by reducing arachidonic acid–derived lipid production.
JJKK-048, a benzodioxol derivative, has been found to a MAGL inhibitor that could probably be significant in anticancer and anti-inflammatory studies.
Several types of compounds have been reported to inhibit MAGL, but only a few compounds represent sufficient selectivity and potency enabling their use in vivo. Especially important is to achieve selectivity between MAGL and fatty acid amide hydrolase (FAAH), the primary enzyme responsible for the degradation of AEA, since dual inhibition of MAGL and FAAH have been demonstrated to induce behavioral effects similar to those achieved with direct CB1 receptor agonists, including catalepsy. The sulfhydryl reagent N-arachidonoylmaleimide and a carbamate compound biphenyl-3-ylcarbamic acid cyclohexyl ester (URB602)were among the first compounds showing activity in vivo, but their potency and MAGL selectivity were proved to be insufficient. More recently, the carbamate compounds 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) and its derivative 1,1,1,3,3,3-hexafluoropropan-2-yl 4-(bis(benzo[d]dioxol-5-yl)(hydroxy)methyl) piperidine-1-carboxylate (KML29) were reported as selective MAGL inhibitors that increase brain 2-AG levels and display a more restricted set of behavioral effects when compared with the CB1 agonists or the dual MAGL and FAAH inhibitors. Carbamate-based inhibitors typically inactivate serine hydrolases by an irreversible covalent modification (carbamoylation) of the catalytic serine nucleophile.

We have characterized piperazine and piperidine triazole ureas as potent and selective inhibitors of MAGL (Aaltonen et al., 2013). Our work culminated in the synthesis of compound {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048), which in vitro is the most potent and MAGL-selective inhibitor currently available. In the present study, we extend our initial study by testing the in vivo effects of JJKK-048. We provide evidence that JJKK-048 exhibits extremely high potency in inhibiting MAGL in the brain and peripheral tissues and maintains good selectivity over other serine hydrolases. We observed that acute administration of JJKK-048 remarkably increased mouse brain 2-AG levels without affecting AEA levels. According to behavioral experiments, JJKK-048 induced antinociception and dose-dependent hypomotility and hypothermia but no catalepsy. Among these in vivo effects, only the antinociceptive effect of JJKK-048 was blocked by rimonabant, suggesting non-CB1-mediated effects of JJKK-048 in behavioral tests.

(2) Proposed Mechanism of MAGL Inhibition by JJKK-048


In competitive ABPP, JJKK-048 prevented TAMRA-fluorophosphonate (FP) labeling of the MAGL active site serine (S122), suggesting that the inhibitor probably targets this catalytic residue. Fast dilution of JJKK-048-treated MAGL preparation did not result in time-dependent drop of inhibitor potency, suggesting further that JJKK-048 (similarly to the established irreversibly acting inhibitor MAFP) inhibited MAGL in a covalent manner. We therefore propose that the triazole acts as the leaving group and that JJKK-048 binds to the active site S122, forming a carbamate adduct. A similar reaction mechanism has been proposed for the triazole compound SAR629. Despite extensive efforts, we could not unambiguously confirm the presence of the JJKK-048-MAGL adduct with a mass spectrometric approach (see Supplemental Results).

In functional autoradiography, JJKK-046 and JJKK-048 evoked the MAFP-mimicking and AM251-sensitive GTPγS-binding responses. This was not due to direct CB1R activation, as in membrane GTPγS-binding assays assessing direct CB1R agonism, these compounds showed no agonist activity at CB1R (or CB2R) at concentrations up to 10−5 M. Thus, the MAFP-mimicking CB1R activity was due to inhibition of 2-AG (but not arachidonoyl ethanolamide, anandamide [AEA]) hydrolysis (see below). Notably, JJKK-046 showed moderate CB1R antagonist activity at concentrations ≥10−6 M (Table S2), a finding likely explaining the relatively modest response for this compound in functional autoradiography.

(3) JJKK-048 Exhibits Remarkable MAGL Selectivity


Liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis of endocannabinoid levels in inhibitor-treated brain sections indicated that JJKK-046 and JJKK-048, when tested at 1 μM final concentration (i.e., ∼3,700- and ∼4,700-fold higher concentrations than their respective IC50 values for MAGL), selectively increased tissue levels of 2-AG but not those of AEA . However, tissue AEA levels were significantly elevated with 10−5 M JJKK-046. In the same experiment, SAR629 and AKU-005 elevated tissue levels of both 2-AG and AEA, as would be expected from their potent dual inhibitory action on MAGL and FAAH.

Activity assays using rat and human FAAH preparations revealed that the two inhibitors exhibited notable MAGL selectivity over FAAH (JJKK-046 > 1,200-fold, JJKK-048 > 13,000-fold) (Table 4). Activity assays with human ABHD6 indicated that JJKK-046 possessed moderate inhibitor activity toward human ABHD6 (hABHD6) (160-fold MAGL selectivity), whereas for JJKK-048, the MAGL/ABHD6 selectivity ratio was ∼630-fold (Table 4). When tested at concentrations up to 10−6 M, human ABHD12 was resistant to these inhibitors (Table 4). Collectively, these data indicate that JJKK-048 in particular shows remarkable selectivity for MAGL over the other endocannabinoid hydrolases.

(4) Discussion


During their existence, MAGL inhibitors have enabled functional investigation of 2-AG signaling pathways and revealed MAGL’s role in physiological and pathophysiological processes. Sufficient potency and selectivity over other enzymes are required from an inhibitor intended to be used in vivo. Especially important is to achieve selectivity between MAGL and FAAH to avoid CB1 agonist-like cataleptic behavior. Selective MAGL inhibitors would provide means to treat conditions where increased 2-AG activity would be beneficial, including pain and neurodegenerative diseases.

(5) Conclusions


Based on the present findings, JJKK-048 can be used to globally inactivate MAGL in both brain and peripheral tissues. JJKK-048 induced a massive increase in mouse brain 2-AG levels without affecting AEA levels. According to ABPP experiments, JJKK-048 remained selective over FAAH, and the only off-target in brain was ABHD6. JJKK-048 appeared to be an extremely potent MAGL inhibitor in vivo, exhibiting a slowly reversible mechanism of action. Our results showed that JJKK-048 promoted significant analgesia in the writhing test with the low dose that did not cause cannabimimetic side effects. A higher dose of JJKK-048 induced analgesia both in the writhing test and in the tail-immersion test, as well as hypomotility and hypothermia, but not catalepsy. Based on these observations, JJKK-048 provides a potent pharmacological tool for the further functional characterization of MAGL.

5. Buy JJKK-048 from Reliable JJKK-048 Suppliers online


(1) Reliable JJKK-048 Suppliers online--AASraw


According to market research, many JJKK-048 suppliers cannot provide JJKK-048 powder, especially JJKK-048 powder.As we know, China and India are major suppliers of pharmaceutical raw materials in the world. The price of Indian powder is relatively cheap, and the quality of powder is also conceivable.The price of powder in China varies a lot, but it all depends on the quality of the product.In particular, today, the Chinese government's strict control over the production of powder and its strict inspection of environmental protection have caused a lot of confusion in the price of powder market. The JJKK-048 price is also different.Here, I recommend a JJKK-048 manufacturer--AASraw.

Go to the official website for more details...

(2) The Guide on buy JJKK-048 step by step


♦ Google AASraw, enter into www.aasraw.com.
♦ Search JJKK-048 Powder(1515855-97-6) on AASraw
♦ Find out JJKK-048 Powder windows XP, and write down your requirmnets.
♦ We get your email and talk more details with you.
♦ Confirm the order, then payment done and we will arrange delivery goods for you later.

2018年7月16日星期一

buy tadalafil powder in bulk

buy tadalafil powder in bulk


What is Tadalafil powder?

1. Chemical Formula: C22H19N3O4
2. Molecular Weight: 389.341
3. CAS No: 171596-29-5
4. Description: White Crystalline Powder
5. Usage: Like its predecessor Viagra, Cialis is used to treat erectile dysfunction in men. One of the more embarrassing side effects of post-cycle-therapy is the decreased libido caused by the sudden absence of exaggerated testosterone levels in the body, often leading to ED. If you cann’t get it up after your cycle, get the pill.

Tadalafil is used to treat male sexual function problems (impotence or erectile dysfunction-ED). In combination with sexual stimulation, tadalafil works by increasing blood flow to the penis to help a man get and keep an erection.
Tadalafil is also used to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). It helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate frequently or urgently (including during the middle of the night). Tadalafil is thought to work by relaxing the smooth muscle in the prostate and bladder.

The effects of Cialis (positive effects) are very straightforward and primarily surround ED treatment. ED can be caused by the lack of blood flow into the penis, which Cialis can remedy. However, ED can also be caused by a low libido, which is more commonly due to improper hormone levels in the body, most commonly low testosterone. If a hormone problem exists yet blood flow is fine, Cialis will not remedy the ED issue nor will any PED5 medication. However, while it will remedy a blood flow issue, there are many men who need both issues addressed, blood flow and hormone.
The effects of Cialis have also been used to treat high blood pressure in some cases as the medication will lower blood pressure; in fact, in 2009 Cialis was approved for the treatment of pulmonary arterial hypertension. In 2011 it was then approved for the treatment of BPH as it was shown to reduce pressure around the prostate and urinary tract.

Why so many people love this sex enhancing drug?
Why people love this sex enhancing drug?Because Cialis has a longer duration of action. Viagra and Levitra last for around four hours, but Cialis lasts for 36. If a man takes Cialis on Friday evening, he has erection assistance through Sunday afternoon. Both men and women say they like the fact that Cialis allows them to take their eyes off the clock and make love whenever they wish. So Cialis has a clear advantage for dating couples or new lovers still in the hot-and-heavy period who value sexual spontaneity.


Tadalafil powder side effects
There are side effects of Cialis, possible side effects, but they are not guaranteed and normally dependent on genetics and dosing if too much is taken. Like all PED5 inhibitors vision impairment is the most worrisome possible side effect of Cialis; however, Tadalafil has the lowest rate of incident amo ng PED5’s. Other possible yet infrequent side effects of Cialis may include:
Nausea
Vomiting
Headache
Flushness
Sore Muscles
Lower Back Pain
The above side effects of Cialis should last no more than a few hours if they occur and are due to the drugs ability to widen blood vessels. If such effects occur most men will find a lower dose fixes the problem. However, in some cases they may need to seek out alternate PED5’s for their ED or BPH needs.
Important Note: Cialis should not be taken with nitrates due to its ability to lower blood pressure. Nitrates should not be taken for at least 48 hours before Cialis use with most nitrate users needing to avoid this and all PED5's.


Tadalafil powder Reviews
Because of its long active life Cialis is perhaps the top PED5 medication on the market. One dose can keep a man ready for at least two days with some reports of men being able to produce strong erections for up to nearly four days from a single dose. This makes the ED drug far more appealing than its primary competition Viagra and Levitra; however, because we are all different some men will have a better response with Viagra or Levitra. If you have ED and need a PED5 the only way to know which one works best for you is to try all three at different times. You do not and should never take more than one at once and should not take a PED5 with any other type of ED medication as this can lead to serious health concerns.


What Tadalafil powder usually used for?

In the local drugstore, or in the hospital, we can easily see cialis, which is tadalafil. Yes, this is tadalafil powder - one of the most common application is made into drug for the treatment of ED, it is usually in the form of pills or tablets, in addition to this, in fact, tadalafil also used in other occasions, what is, let's look at.

Tadalafil powder for Sexual candy

Tadalafil can be added to candies to make ordinary candies to enhance men's sexual needs. There are very many types of sexual sweets in Malaysia, the main ingredients are usually tadalafil powder,and sildenafil powder.

Tadalafil powder for Sex coffee

In market,there are some kinds of sex coffee.Mainly  Ingredients usually are:Coconut Milk,Honey,Cinnamon,Cacao,Maca.Sex coffee is late-type of drink with an Aztec twist to it. The flavor is slightly spicy, but sweet enough to appeal to anyone’s taste buds. This sex coffee has the ingredients to effectively boost your libido. Maca, Cacao, Cinnamon, Honey and Coconut Milk collectively help boost hormone production, improve semen quality, delay menopause, lower blood sugar, improve stamina and improve sex drive.

For us,sometimes in order to have stronger effects or weaker effects,we can made sex coffee by adding sex enhancing powder tadalafil, according to client's need to make different degree effects coffee. That means, tadalafil powder can helps to be made into sex coffee.

Tadalafil powder for Sex wine/drink

He could also be added to health care. Alcohol itself has increased the effect of blood flow, it is understood that we have common red wine can increase blood flow for women, for men to increase the level of testosterone in the blood, but the effect of the wine to be mild. And the addition of the powder to the powder can be adjusted to the amount needed, and the health drink is more popular with men in the market, especially middle-aged men.


You can find many Tadalafil powder source online, but it is hard to buy Genuine Tadalafil powder online. There are many sources selling fake products at the market. so when you buy Tadalafil raw material online, you need to choose an realiable source.

2018年7月15日星期日

Sibutramine in treating obesity:You must know more about sibutramine!!!

Sibutramine in treating obesity:You must know more about sibutramine!!!

What is sibutramine?

Sibutramine is a medication that assists with weight-loss by altering neurotransmitters within 99% purity Sibutramine in weight loss will from AASRAW steroid powder.the brain. Neurotransmitters are chemicals that are produced and released by nerves in order to communicate with other nerves. Released neurotransmitters may attach to other nerves or they may be taken up again by the nerves that release them, a process termed reuptake. Sibutramine blocks the reuptake of the neurotransmitters dopamine, norepinephrine, and serotonin. Blocking the reuptake of neurotransmitters alters the balance of neurotransmitters within the nerve cells and thereby affect nerve function and interaction.
Meridia is found to be highly effective in the treatment of obesity as the medication is able to bring down the additional flab in the body in a gradual way spread over a period of time. If the weight loss program is accompanied by a proper diet and right medication like Meridia it leads to a definite reduction in body weight and also opens up the clear passage of healthy life. Obesity is a commonly reported problem affecting many people and it’s also understood by the patients how difficult it is shed the excess weight. When the body has excess weight it becomes a persisting problem for the individual to perform even simple tasks. With obesity as the main ailment, other issues also step into the body and make the affected person suffer on the whole.

Sibutramine Mechanism of Action

  1. Sibutramine (the active ingredient in Meridia) is a powerful central nervous system stimulant similar to amphetamines, and chemically related to Phentermine ( the active ingredient in the weight loss drug Adipex).
  2. Sibutramine works by increasing Serotonin and Norepinephrine levels in the brain, which leads to appetite suppression.
  3. This drug was initially developed as an antidepressant, and later approved by the FDA for the treatment of obesity.

How does sibutramine works?

Sibutramine offers three types of benefit in weight management: by enhancing weight loss, by improving weight maintenance and by reducing the comorbidities of obesity. The clinical effects of sibutramine are explained through its known mode of action as a serotonin (5-HT) and noradrenaline reuptake inhibitor (SNRI). This dual mechanism of action results in two synergistic physiological effects--a reduction in energy intake and an increase in energy expenditure, which combine to promote and maintain weight loss.

How to Use Sibutramine hydrochloride?

Sibutramine is usually taken 10-15mg a time,once daily. Follow your doctor's instructions.Your doctor may occasionally change your dose to make sure you get the best results.Take exactly as prescribed by your doctor. Do not take in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.
Sibutramine can be taken with or without food.You should lose at least 4 pounds during the first 4 weeks of taking sibutramine and eating a low calorie diet. Tell your doctor if you do not lose at least 4 pounds after taking the medication for 4 weeks.
Sibutramine should not be taken for longer than 2 years.Store at room temperature away from moisture, heat, and light.Do not share sibutramine with another person. Keep the medication in a place where others cannot get to it.
Your blood pressure and pulse will need to be checked often. Visit your doctor regularly.Overdose symptoms may include headache, dizziness, and fast heart rate.
Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

Sibutramine Dosage

Usual Adult Dose for Obesity
Sibutramine was voluntarily withdrawn from the US market by the manufacturer in October, 2010 due to clinical trial data indicating an increased risk of heart attack and stroke. The following dosage information applies to when the drug was available in the US.
Initial Dose: 10 mg orally once a day.
Usual Geriatric Dose for Obesity
Sibutramine was voluntarily withdrawn from the US market by the manufacturer in October, 2010 due to clinical trial data indicating an increased risk of heart attack and stroke. The following dosage information applies to when the drug was available in the US.
Clinical studies of sibutramine did not include sufficient numbers of patients over 65 years of age. Sibutramine is contraindicated in this group of patients.
Usual Pediatric Dose for Obesity
Sibutramine was voluntarily withdrawn from the US market by the manufacturer in October, 2010 due to clinical trial data indicating an increased risk of heart attack and stroke. The following dosage information applies to when the drug was available in the US.
Based on one study (n=60)
14 to 17 years:
Initial Dose: 10 mg orally once a day.

The recipe of sibutramine(Making by yourself)

About sibutramine hydrochloride Customers use  feedback solutions(The recipe is for reference only):
1. Our products are sibutramine hydrochloride, purity 99%, pharmaceutical grade.
2. The commonly used method in the market is
  1). Mixed sweet potato leaves, lotus leaves, coffee powder and other plant extracts, such plant extracts are alkaline substances, with sibutramine hydrochloride mixed use, acid-base neutralization, reduce or lead to product weight loss effect instability.
  2). Direct use of sibutramine hydrochloride, each capsule content 20-30mg, daily dose not exceed 200mg.
  3). From the pharmacy, it is recommended that the use of grape sugar and sibutramine hydrochloride mixed capsules, recommended dose 30mg.
3. Recommendations on the production of equipment:
  1). The use of air pressure filling equipment to ensure that the net content of each capsule to achieve the specified value.
  2). The use of mechanical mixing equipment to ensure that the drug and other accessories fully mixed.
4. With regard to testing
Customers are recommended to use our products directly in the third-party laboratory or Annex University chemical laboratory testing, with a test report, can be reimbursed for testing costs and sample costs.

IFrame

Sibutramine treat obesity(Sibutramine's application field)

Even if sibutramine has serious side effects, it is still a lot of weight loss products manufacturers, the most important raw materials in use, such as weight loss coffee, diet drink, jelly, etc., to lose weight is inseparable from the use of sibutramine.Adding proper sibutramine powder in these products can help improve the timeliness of medicine and help customers to achieve the desire to lose weight.

How sibutramine works in treating obesity?

Sibutramine(Meridia) has a direct influence on the brain as the very first step after the taking Meridia. As the nervous system acts as the center for controlling all the physical activities in the body, it becomes essential for the pill to propel its action in the brain. Meridia interacts with the chemicals in the nervous system that have a direct impact on the weight of the body.
The pill is suggested by experts to be taken as a blend with the daily diet to see the actual results within a specified time frame. Obesity is found to lead to other problems like spike in blood pressure, and other health issues like diabetes. The diet intake should be of low calorie along with an appropriate exercise regimen.

How effective is sibutramine in treating obesity?

Sibutramine(Meridia) is found to be highly effective in the treatment of obesity as the medication is able to bring down the additional flab in the body in a gradual way spread over a period of time. If the weight loss program is accompanied by a proper diet and right medication like Meridia it leads to a definite reduction in body weight and also opens up the clear passage of healthy life. Obesity is a commonly reported problem affecting many people and it’s also understood by the patients how difficult it is shed the excess weight. When the body has excess weight it becomes a persisting problem for the individual to perform even simple tasks. With obesity as the main ailment, other issues also step into the body and make the affected person suffer on the whole.
Sibutramine powder in diet tea, weight loss coffee, diet jelly and it works well.

Pay attention on 3 things when making Diet Tea or others

Like this situation, it is said that not only in Singapore, there are many countries in Europe and North America, consumer reaction side effects, the actual effect is not obvious, were found to contain sibutramine, therefore, make the weight loss products manufacturers did not notice the control, the side effects of product after adding sibutramine not grasp good production proportion.
Here, we have to remind manufacturers of weight loss products (diet tea, weight loss coffee, diet jelly, etc.) that manufacturers should pay attention to the following issues:
1. Control the degree of acid and alkali of the product, so as to prevent the salt from being turned into salt in the acid base, resulting in the invalid product;
2. Sibutramine can not be mixed with plant extracts, plant extracts are generally strong alkaline, while sibutramine is strongly acidic, and it will also become salt after blending.
3. If you do not add other recipes properly, you will have obvious side effects: constipation, stain on your face, bad breath, etc.

Sibutramine side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Stop using sibutramine and call your doctor at once if you have a serious side effect such as:
  1. fast, pounding, or uneven heartbeats;
  2. new or worsening shortness of breath;
  3. agitation, hallucinations, fever, tremor, overactive reflexes, nausea, vomiting, diarrhea, loss of coordination, dilated pupils;
  4. very stiff (rigid) muscles, high fever, sweating, confusion, feeling like you might pass out;
  5. easy bruising or bleeding (nosebleeds, bleeding gums, or any bleeding that will not stop);
  6. dangerously high blood pressure (severe headache, blurred vision, buzzing in your ears, anxiety, seizure);
  7. chest pain or heavy feeling, pain spreading to the arm or shoulder, general ill feeling; or
  8. sudden numbness or weakness (especially on one side of the body), problems with vision, speech, or balance.

What should I avoid while taking sibutramine(Warning of sibutramine)?

Sibutramine may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert.
Do not take any other prescription or over-the-counter weight-loss products without your doctor's advice.
Avoid taking cough and cold or allergy medications while taking sibutramine.
Avoid drinking alcohol while taking sibutramine.

buy 99% purity Sibutramine powder in weight loss will from AASRAW steroid powder.Sibutramine price
The price of sibutramine in the market is relatively expensive, especially for capsules and tablets, which will add a variety of materials to make, making its own value and price are out of proportion.
It is reasonable to choose the high purity of sibutramine powder, the powder is easy to test the purity, and can quickly distinguish the value of it.So sibutramine powder may be a better choice for users.
Here give a reference value,In general,sibutramine:USD50/10g,USD160/100g.

Buy sibutramine powder online

Visit our online pharmacy (AASRAW)and fill in an order of Meridia (Sibutramine). Define place of delivery, quantity of the product and the way of payment. In the period of 30 minutes, you will receive a confirmation of your order. It will be delivered within 10 business days.
100% Quality. We work only with licensed and reliable suppliers, which allow us to offer you best quality products at a very good price. Any product we offer (brand or generic) is a product which gained a very good reputation among our customers and was acknowledged by FDA.
Online order status check. We offer our customers a very convenient option to receive an update on order status. You can see the progress of your order beginning from the placement up to the delivery. Moreover you can contact our 24/7 support and receive any information you need without going online.
We accept bank transfer,WesternUnion Payment,MoneyGram Payment, Bitcoins....
We are able to ship to the following countries: United States, Canada, UK (Great Britain), Australia, Belgium, Denmark, Finland, France, Greece, Ireland, Italy, Spain.ect.
We have a guaranteed delivery. The standard shipping period takes from 14 to 28 business days. The order will be shipped via Registered airmail.
In case of any problems with the order we will offer you a free of charge re-shipment or a full refund of the amount.
More please read web site:www.aasraw.com.